Central Pacific Bank - Trust Division’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Central Pacific Bank - Trust Division's BMY Position: Q2 2026 in Review
Central Pacific Bank - Trust Division reduced its Bristol-Myers Squibb (BMY) stake by 7.2% in Q2 2026, selling an estimated $53.4K and leaving 12,054 shares worth $695K. The position accounts for 0.07% of the portfolio, ranked #261.
Central Pacific Bank - Trust Division first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.04M in Q1 2025. 1,157 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Central Pacific Bank - Trust Division held 12,054 shares of Bristol-Myers Squibb worth $695K as of Q2 2026.
- Central Pacific Bank - Trust Division sold 930 Bristol-Myers Squibb shares in Q2 2026, an estimated $53.4K.
- Bristol-Myers Squibb made up 0.07% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #261 holding.
- Central Pacific Bank - Trust Division first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
- Central Pacific Bank - Trust Division's Bristol-Myers Squibb position peaked at $1.04M in Q1 2025.
- 1,157 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.